Back to Search Start Over

Olfactory decline develops in parallel with frailty in older US adults with obstructive lung diseases.

Authors :
Wang, Esther
Wroblewski, Kristen E.
McClintock, Martha K.
Pinto, Jayant M.
Witt, Leah J.
Source :
International Forum of Allergy & Rhinology. Apr2024, Vol. 14 Issue 4, p819-827. 9p.
Publication Year :
2024

Abstract

Background: Frailty is prevalent among older adults with asthma or chronic obstructive pulmonary disease (obstructive lung diseases [OLDs]). Frailty and OLD's co‐occurrence is associated with increased hospitalization/mortality. Chemosensory dysfunction is closely connected to both OLD and frailty. We evaluated the utility of olfactory decline as a biomarker of frailty in the setting of OLD. Methods: We performed a prospective, longitudinal, nationally representative study of community‐dwelling older US adults in the National Social Life, Health and Aging Project, an omnibus in‐home survey. Respondents reported a physician's diagnosis of OLD. Decline in odor identification and sensitivity over 5 years and frailty (adapted fried frailty phenotype criteria) were measured using standard tools. Multivariate logistic regressions evaluated the association between OLD status, olfactory decline, and frailty. Results: We compared individuals with OLD (n = 98; mean age 71.2 years, 59.2% women) and those without OLD (n = 1036; mean age 69.5 years, 58.9% women). Olfactory identification decline was associated with developing frailty over the 5‐year follow‐up period in individuals with OLD (odds ratio [OR] = 9.1, 95% confidence interval [CI] = 2.1–38.6, p = 0.003). Olfactory decline predicted incidence of frailty in individuals with OLD (identification: OR = 4.8, 95% CI = 1.3–17.5, P = 0.018; sensitivity: OR = 6.1, 95%CI = 1.2–31.0, p = 0.030) but not in those without OLD adjusting for demographics, heavy alcohol use, current smoking, and comorbidity. Results were robust to different thresholds for olfactory decline and frailty development. Conclusions: Older adults with OLD who experience olfactory decline face higher odds of developing frailty. Use of olfactory decline as a biomarker to identify frailty could allow earlier intervention and decrease adverse outcomes for high‐risk older adults with OLD. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
20426976
Volume :
14
Issue :
4
Database :
Academic Search Index
Journal :
International Forum of Allergy & Rhinology
Publication Type :
Academic Journal
Accession number :
176353656
Full Text :
https://doi.org/10.1002/alr.23273